From the Gut to the Brain: Journey and Pathophysiological Effects of the Food-associated Trichothecene Mycotoxin Deoxynivalenol

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2013 Apr 25

PMID 23612752

Citations 137

Authors

Marc Maresca

Affiliations

Soon will be listed here.

Abstract

Mycotoxins are fungal secondary metabolites contaminating food and causing toxicity to animals and humans. Among the various mycotoxins found in crops used for food and feed production, the trichothecene toxin deoxynivalenol (DON or vomitoxin) is one of the most prevalent and hazardous. In addition to native toxins, food also contains a large amount of plant and fungal derivatives of DON, including acetyl-DON (3 and 15ADON), glucoside-DON (D3G), and potentially animal derivatives such as glucuronide metabolites (D3 and D15GA) present in animal tissues (e.g., blood, muscle and liver tissue). The present review summarizes previous and very recent experimental data collected in vivo and in vitro regarding the transport, detoxification/metabolism and physiological impact of DON and its derivatives on intestinal, immune, endocrine and neurologic functions during their journey from the gut to the brain.

Citing Articles

Identification and characterization of Morganella morganii strain YC12-C3 and Enterococcus faecalis strain YC12-C10 and elucidation of its deoxynivalenol-degrading potential.

An J, Chen Y, Zhou S, Gao Y, Yang C, Zhang J Mycotoxin Res. 2024; 41(1):113-126.

PMID: 39446283 DOI: 10.1007/s12550-024-00568-9.

A review of pathogenic airborne fungi and bacteria: unveiling occurrence, sources, and profound human health implication.

Al-Shaarani A, Pecoraro L Front Microbiol. 2024; 15:1428415.

PMID: 39364169 PMC: 11446796. DOI: 10.3389/fmicb.2024.1428415.

Natural products for Gut-X axis: pharmacology, toxicology and microbiology in mycotoxin-caused diseases.

Li K, Wang S, Qu W, Ahmed A, Enneb W, Obeidat M Front Pharmacol. 2024; 15:1419844.

PMID: 38978980 PMC: 11228701. DOI: 10.3389/fphar.2024.1419844.

Are Infants and Children at Risk of Adverse Health Effects from Dietary Deoxynivalenol Exposure? An Integrative Review.

Gonya S, Kallmerten P, Dinapoli P Int J Environ Res Public Health. 2024; 21(6).

PMID: 38929054 PMC: 11204095. DOI: 10.3390/ijerph21060808.

A new bacterial consortia for management of Fusarium head blight in wheat.

Thuraga V, Ghadamgahi F, Dadi F, Vetukuri R, Chawade A Sci Rep. 2024; 14(1):10131.

PMID: 38698085 PMC: 11066059. DOI: 10.1038/s41598-024-60356-4.

References

DallErta A, Cirlini M, DallAsta M, Del Rio D, Galaverna G, DallAsta C . Masked mycotoxins are efficiently hydrolyzed by human colonic microbiota releasing their aglycones. Chem Res Toxicol. 2013; 26(3):305-12. DOI: 10.1021/tx300438c. View

Miller K, Atkinson H . The in vitro effects of trichothecenes on the immune system. Food Chem Toxicol. 1986; 24(6-7):545-9. DOI: 10.1016/0278-6915(86)90111-0. View

Sobrova P, Adam V, Vasatkova A, Beklova M, Zeman L, Kizek R . Deoxynivalenol and its toxicity. Interdiscip Toxicol. 2011; 3(3):94-9. PMC: 2984136. DOI: 10.2478/v10102-010-0019-x. View

Schothorst R, van Egmond H . Report from SCOOP task 3.2.10 "collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states". Subtask: trichothecenes. Toxicol Lett. 2004; 153(1):133-43. DOI: 10.1016/j.toxlet.2004.04.045. View

Virelizier J . Immunological functions of macrophages and their regulation by interferons. Med Biol. 1985; 63(4):149-59. View

Kluger B, Bueschl C, Lemmens M, Berthiller F, Haubl G, Jaunecker G . Stable isotopic labelling-assisted untargeted metabolic profiling reveals novel conjugates of the mycotoxin deoxynivalenol in wheat. Anal Bioanal Chem. 2012; 405(15):5031-6. PMC: 3656241. DOI: 10.1007/s00216-012-6483-8. View

Van De Walle J, During A, Piront N, Toussaint O, Schneider Y, Larondelle Y . Physio-pathological parameters affect the activation of inflammatory pathways by deoxynivalenol in Caco-2 cells. Toxicol In Vitro. 2010; 24(7):1890-8. DOI: 10.1016/j.tiv.2010.07.008. View

Maresca M, Yahi N, Younes-Sakr L, Boyron M, Caporiccio B, Fantini J . Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the.... Toxicol Appl Pharmacol. 2008; 228(1):84-92. DOI: 10.1016/j.taap.2007.11.013. View

Streit E, Schatzmayr G, Tassis P, Tzika E, Marin D, Taranu I . Current situation of mycotoxin contamination and co-occurrence in animal feed--focus on Europe. Toxins (Basel). 2012; 4(10):788-809. PMC: 3496989. DOI: 10.3390/toxins4100788. View

10.

Diesing A, Nossol C, Danicke S, Walk N, Post A, Kahlert S . Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application. PLoS One. 2011; 6(2):e17472. PMC: 3045462. DOI: 10.1371/journal.pone.0017472. View

11.

Amuzie C, Pestka J . Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation. Toxicol Sci. 2009; 113(2):412-21. PMC: 2902918. DOI: 10.1093/toxsci/kfp225. View

12.

Ren K, Dubner R . Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol. 2008; 21(5):570-9. PMC: 2735048. DOI: 10.1097/ACO.0b013e32830edbdf. View

13.

Bouhet S, Oswald I . The intestine as a possible target for fumonisin toxicity. Mol Nutr Food Res. 2007; 51(8):925-31. DOI: 10.1002/mnfr.200600266. View

14.

Yee S . In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth. Pharm Res. 1997; 14(6):763-6. DOI: 10.1023/a:1012102522787. View

15.

Pestka J, Zhou H, Moon Y, Chung Y . Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett. 2004; 153(1):61-73. DOI: 10.1016/j.toxlet.2004.04.023. View

16.

Razafimanjato H, Benzaria A, Taieb N, Guo X, Vidal N, Di Scala C . The ribotoxin deoxynivalenol affects the viability and functions of glial cells. Glia. 2011; 59(11):1672-83. DOI: 10.1002/glia.21214. View

17.

Atkinson H, Miller K . Inhibitory effect of deoxynivalenol, 3-acetyldeoxynivalenol and zearalenone on induction of rat and human lymphocyte proliferation. Toxicol Lett. 1984; 23(2):215-21. DOI: 10.1016/0378-4274(84)90129-2. View

18.

Videmann B, Tep J, Cavret S, Lecoeur S . Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food Chem Toxicol. 2007; 45(10):1938-47. DOI: 10.1016/j.fct.2007.04.011. View

19.

Turner P, Flannery B, Isitt C, Ali M, Pestka J . The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr Res Rev. 2012; 25(1):162-79. DOI: 10.1017/S095442241200008X. View

20.

Gibbs M, Hutchinson D, Hertz L . Astrocytic involvement in learning and memory consolidation. Neurosci Biobehav Rev. 2008; 32(5):927-44. DOI: 10.1016/j.neubiorev.2008.02.001. View